United States Patent and Trademark Office, Patent Assignment 21108/395: Assignment Of Assignors Interest
Assignors
Assignee
Basi, Guriq Paperwork Executed April 10, 2002
Saldanha, Jose Paperwork Executed July 3, 2002
Yednock, Ted Paperwork Executed April 10, 2002
Recorded
Elan Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
Patents
Correspondent
Humanized Antibodies That Recognize Beta Amyloid Peptide
X0 Patent Application No.10232030 , Filed August 30, 2002
A1 Application Publication No.
Humanized Antibodies That Recognize Beta Amyloid Peptide
B2 Utility Patent No.7582733 , Issued September 1, 2009
Rosemarie L. Celli
Updated September 1, 2009
View this assignment via USPTO Assignments on the Web
Statistics
This assignment has been viewed 2 times.
Information Facts
https://www.plainsite.org/patents/assignment.html?id=4180134
Primary Sources Government agencies: SEC/EDGAR, federal and state courts, USPTO, IRS, and others
AI text generation None AI document summarization None AI-augmented search None AI-generated images None AI chat or Q&A interface Linkable via MCP Third party AI contribution in government documents Possible
Document content is reproduced directly from government sources. Some filings in our database may themselves contain AI-generated content submitted by third parties to government agencies.
